CYP19A1 and polycystic ovary syndrome: Because neither the Food and Drug Administration (FDA) nor the European Medicines Agency has ever authorized a medication, particularly for PCOS treatment, most medicines that are taken for PCOS treatment, from oral contraceptives to insulin sensitizers, aromatase, or antiandrogen inhibitors, are used off-label.